Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9311829 | Urology | 2005 | 5 Pages |
Abstract
Co-administration of intranasal PT-141 and a phosphodiesterase type 5 inhibitor may constitute a treatment alternative for patients in whom higher doses of a single therapy are not effective or well tolerated.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
L.E. Diamond, D.C. Earle, W.D. Garcia, C. Spana,